De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer

BACKGROUND: Metastatic epidermal growth factor receptor-mutated (EGFR(+)) non-small-cell lung cancer (NSCLC) can present de novo or following previous nonmetastatic disease (secondary). Potential differences between these two patient subsets are unclear at present. METHODS: We retrospectively analyz...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Oncol
Asıl Yazarlar: Bozorgmehr, Farastuk, Kazdal, Daniel, Chung, Inn, Kirchner, Martina, Magios, Nikolaus, Kriegsmann, Mark, Allgäuer, Michael, Klotz, Laura V., Muley, Thomas, El Shafie, Rami A., Fischer, Jürgen R., Faehling, Martin, Stenzinger, Albrecht, Thomas, Michael, Christopoulos, Petros
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2021
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8063726/
https://ncbi.nlm.nih.gov/pubmed/33898315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.640048
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller